Ticker

No recent analyst price targets found for RVLCF.

Latest News for RVLCF

US-China AI Rivalry Grows With Alibaba's Anthropic Rival

New Chinese AI models including Alibaba's flagship system that claims performance similar to Anthropic's Fable is intensifying the rivalry between China and the US over AI. Bloomberg's Minmin Low has the latest.

Bloomberg Markets and Finance • Aug 4, 2026
Novo Nordisk's Wegovy Pill Escalates Eli Lilly Rivalry

Novo Nordisk regains competitive ground in obesity with the strong launch of the Wegovy pill, reversing some of the recent underperformance against Eli Lilly. NVO's Wegovy pill outpaces Eli Lilly's Foundayo in new-to-brand prescriptions, driven by superior weight loss efficacy and fewer drug interaction restrictions. Despite setbacks, NVO is advancing late-stage candidates like CagriSema, UBT251, and zenagamtide,…

Seeking Alpha • Jul 9, 2026

🧮 Earnings Move Analyzer

Insider Trading

No insider trades found for RVLCF.

No Senate trades found for RVLCF.

No House trades found for RVLCF.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top